Neurocords
Spinal Cord Treatment Technology
Startup Acquired Health Tech & Life Sciences Est. 2018
Total Raised
Undisclosed
Acquired
Last Round
Undisclosed
Team
0
0 employees
Confidence
46/100
News
1
articles
About
Neurocords is developing regenerative therapies for spinal cord injuries. Its focus is on a novel cellular therapy platform aimed at restoring function following spinal cord injuries.
Classification
Sector
Health Tech & Life SciencesPharma & Medical Biotechnology
Business Model
B2B
Funding & Events
Mar 2025
Exit Undisclosed
News (1)
Mar 7, 2025 · www.biospace.com
growth-positive
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
AcquisitionPartners
Details
Product Stage
Released
Employees
0
District
Center District
Founded
2018
Registrar
515813897
Locations
HaRakevet St 58, Tel Aviv-Yafo, Israel
Links
Admin
Last Update
Mar 26, 2025
Verified by
Yanina Wainscheinker
Missing
sector, tags, invite member, logo, description, homepage, video or image, funding rounds, markets, external profiles, not claimed
Internal
Created by
Maor Perlov (maor.perlov@sncentral.org)
Created
2025-03-25T00:00:00.000Z
Status
Acquired by Orgenesis on Mar, 2025
Finder · Neurocords · 2026